Εμφανίζονται 1 - 20 Αποτελέσματα από 32 για την αναζήτηση '"ПЕРЕДНЯЯ ПОВЕРХНОСТЬ"', χρόνος αναζήτησης: 0,63δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Πηγή: Ophthalmology in Russia; Том 17, № 1 (2020); 105-110 ; Офтальмология; Том 17, № 1 (2020); 105-110 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2020-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.ophthalmojournal.com/opht/article/view/1141/677; European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition — Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options. Br J Ophthalmol. 2017;101(6):130–195. DOI:10.1136/bjophthalmol2016-EGSguideline.003; Pflugfelder S.C., Baudouin C. Challenges in the clinical measurement of ocular surface disease in glaucoma patients. Clin Ophthalmol. 2011;5:1575–1583. DOI:10.2147/opth.s24410; Boimer C., Birt C.M. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study. J Glaucoma. 2013;22:730–735. DOI:10.1097/ IJG.0b013e31825af67d; Miki T., Naito T., Fujiwara M. Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy. PLoS One. 2017;12(7):e0181550. Published 2017 Jul 20. DOI:10.1371/journal.pone.0181550; Kaštelan S., Tomić M., Metež Soldo K., Salopek-Rabatić J. How ocular surface disease impacts the glaucoma treatment outcome. Biomed Res Int. 2013;2013:696328. DOI:10.1155/2013/696328; Broadway D.C., Grierson I., O’Brien C., Hitchings R.A. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Archives of Ophthalmology. 1994;112(11):1446–1454.; Thygesen J. Glaucoma therapy: preservative-free for all? Clin Ophthalmol. 2018;12:707–717. Published 2018 Apr 13. DOI:10.2147/OPTH.S150816; Hirooka K., Nitta E., Ukegawa K., Tsujikawa A. Vision-related quality of life following glaucoma filtration surgery. BMC Ophthalmol. 2017;17(1):66. Published 2017 May 12. DOI:10.1186/s12886-017-0466-7; Ji H., Zhu Y., Zhang Y., et al. The Effect of Dry Eye Disease on Scar Formation in Rabbit Glaucoma Filtration Surgery. Int J Mol Sci. 2017;18(6):1150. Published 2017 May 28. DOI:10.3390/ijms18061150; King A.J., Fernie G., Azuara-Blanco A., et al. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. Br J Ophthalmol. 2018;102(7):922–928. DOI:10.1136/ bjophthalmol-2017-310902; Lee S.Y., Wong T.T., Chua J., Boo C., Soh Y.F., Tong L. Effect of chronic antiglaucoma medications and trabeculectomy on tear osmolarity. Eye (Lond). 2013;27(10):1142–1150. DOI:10.1038/eye.2013.144; Allergan I. Accessed March 31, 2013; Ocular Surface Disease Index (OSDI). The Dry Eye Zone website, 1995. Available at: http://www.dryeyezone.com/encyclopedia/documents/OSDI.pdf; Burstein N.L. The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Trans Ophthalmol Soc U K. 1985;104( Pt 4):402–409. Review.; Zhu W., Kong X., Xu J., Sun X. Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study. J Ophthalmol. 2015;2015:165475. DOI:10.1155/2015/165475; Herreras J.M., Pastor J.C., Calonge M., Asensio V.M. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology. 1992;99:1082–1088.; Pauly A., Brignole-Baudouin F., Labbe A., et al. New tools for the evaluation of toxic ocular surface changes in the rat. Invest. Ophthalmol. Vis. Sci. 2007;48:5473–5483.; https://www.ophthalmojournal.com/opht/article/view/1141

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20